Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron before coronary artery bypass graft surgery
IRCT20130814014359N6Phase 3Recruiting
- Sponsor
- Guilan University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Hemoglobin. Started Feb 2026; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20130814014359N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130814014359N6.